CEBP AACR Membership Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rudolph, R. E.
Right arrow Articles by Potter, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rudolph, R. E.
Right arrow Articles by Potter, J. D.
Cancer Epidemiology Biomarkers & Prevention Vol. 14, 605-608, March 2005
© 2005 American Association for Cancer Research

Risk Factors for Colorectal Cancer in Relation to Number and Size of Aberrant Crypt Foci in Humans

Rebecca E. Rudolph1,2,3, Jason A. Dominitz1,3, Johanna W. Lampe2,4, Lisa Levy2, Pingping Qu2, Shuying S. Li2, Paul D. Lampe2,5, Mary P. Bronner6 and John D. Potter2,4

1 Veterans Affairs Puget Sound Health Care System; 2 Cancer Prevention Program, Fred Hutchinson Cancer Research Center; Departments of 3 Medicine, 4 Epidemiology, and 5 Pathobiology, University of Washington, Seattle, Washington; and 6 Department of Anatomic Pathology, Cleveland Clinic Foundation, Cleveland, Ohio

Requests for reprints: Rebecca E. Rudolph, Fred Hutchinson Cancer Research Center, P.O. Box 19024, M3-B232, Seattle, WA 98109-1024. Phone: 206-667-4678; Fax: 206-667-5977. E-mail: rrudolph{at}fhcrc.org

Several characteristics of aberrant crypt foci (ACF) suggest that they are precursors of colorectal cancer, but the factors that promote or inhibit their growth are largely unknown. We conducted a pilot study to explore whether factors associated with risk of colorectal cancer are also associated with number or size of rectal ACF. Thirty-two U.S. veterans, ages 50 to 80 years, were recruited to undergo magnifying chromoendoscopy for imaging of rectal ACF and colonoscopy for identification of polyps or cancer. Participants completed a questionnaire on cigarette smoking, use of nonsteroidal anti-inflammatory drugs (NSAIDs), and family history of colorectal cancer. Fisher's exact test was used to assess the statistical significance of associations between colorectal cancer risk factors and characteristics of ACF. Cochran-Mantel-Haenszel statistics and polytomous regression were used to test the significance of associations adjusted for age. Participants with a history of adenoma had more ACF than those without (age-adjusted P = 0.02), but the numbers in the two groups overlapped markedly. Older participants had more (P = 0.06) and larger (P = 0.009) ACF than younger participants. No associations were identified between either ACF number or size and cigarette smoking, use of NSAIDs, or family history of colorectal cancer. These findings suggest that persons with adenomas have somewhat more rectal ACF than persons without, and that older age is a risk factor for ACF growth. Future research should be directed toward developing techniques to identify ACF that are likely to progress to cancer and the modifiable factors that promote or inhibit such progression.




This article has been cited by other articles:


Home page
Hum Exp ToxicolHome page
L Ziliotto, L. Barbisan, and M. Rodrigues
Lack of chemoprevention of dietary Agaricus blazei against rat colonic aberrant crypt foci
Human and Experimental Toxicology, June 1, 2008; 27(6): 505 - 511.
[Abstract] [PDF]


Home page
Cancer Prevention ResearchHome page
P. Lance and S. R. Hamilton
Sporadic Aberrant Crypt Foci Are Not a Surrogate Endpoint for Colorectal Adenoma Prevention
Cancer Prevention Research, June 1, 2008; 1(1): 4 - 8.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Kim, J. Ng, A. Arozulllah, R. Ewing, X. Llor, R. E. Carroll, and R. V. Benya
Aberrant Crypt Focus Size Predicts Distal Polyp Histopathology
Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1155 - 1162.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
O. K. Glebov, L. M. Rodriguez, P. Soballe, J. DeNobile, J. Cliatt, K. Nakahara, and I. R. Kirsch
Gene Expression Patterns Distinguish Colonoscopically Isolated Human Aberrant Crypt Foci from Normal Colonic Mucosa.
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2253 - 2262.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.